Concurrent RB1 and TP53 alterations define a subset of EGFR-mutant lung cancers at risk for histologic transformation and inferior clinical outcomes

INTRODUCTION: EGFR-mutant lung cancers are clinically and genomically heterogeneous with concurrent RB1/TP53 alterations identifying a subset at increased risk for small cell transformation. The genomic alterations that induce lineage plasticity are unknown. METHODS: Patients with EGFR/RB1/TP53-muta...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Thorac Oncol
Main Authors: Offin, Michael, Chan, Joseph M., Tenet, Megan, Rizvi, Hira A., Shen, Ronglai, Riely, Gregory J., Rekhtman, Natasha, Daneshbod, Yahya, Quintanal-Villalonga, Alvaro, Penson, Alexander, Hellmann, Matthew D., Arcila, Maria E., Ladanyi, Marc, Pe’er, Dana, Kris, Mark G., Rudin, Charles M., Yu, Helena A.
Formato: Artigo
Idioma:Inglês
Publicado em: 2019
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6764905/
https://ncbi.nlm.nih.gov/pubmed/31228622
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jtho.2019.06.002
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados